Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ciprian Catana, Ph.D., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Ciprian Catana and Onofrio Catalano.
Ciprian Catana
Connection Strength
3.126
Onofrio Catalano
  1. Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo). Eur J Nucl Med Mol Imaging. 2018 11; 45(12):2147-2154.
    View in: PubMed
    Score: 0.769
  2. Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases. Invest Radiol. 2021 10 01; 56(10):621-628.
    View in: PubMed
    Score: 0.240
  3. Evaluation of Deep Learning-Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images. J Nucl Med. 2022 Mar; 63(3):468-475.
    View in: PubMed
    Score: 0.237
  4. An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases. Eur J Nucl Med Mol Imaging. 2021 05; 48(5):1522-1537.
    View in: PubMed
    Score: 0.231
  5. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1871-1884.
    View in: PubMed
    Score: 0.211
  6. Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction. J Nucl Med. 2019 03; 60(3):429-435.
    View in: PubMed
    Score: 0.194
  7. Concurrent Respiratory Motion Correction of Abdominal PET and Dynamic Contrast-Enhanced-MRI Using a Compressed Sensing Approach. J Nucl Med. 2018 09; 59(9):1474-1479.
    View in: PubMed
    Score: 0.186
  8. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast. Int J Oncol. 2017 Jul; 51(1):281-288.
    View in: PubMed
    Score: 0.178
  9. Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR. Abdom Radiol (NY). 2017 04; 42(4):1141-1151.
    View in: PubMed
    Score: 0.176
  10. PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype. Br J Cancer. 2017 Mar 28; 116(7):893-902.
    View in: PubMed
    Score: 0.175
  11. An overview of PET/MR, focused on clinical applications. Abdom Radiol (NY). 2017 02; 42(2):631-644.
    View in: PubMed
    Score: 0.174
  12. PET/MRI in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data. J Nucl Med. 2017 05; 58(5):840-845.
    View in: PubMed
    Score: 0.174
  13. Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance. JACC Cardiovasc Imaging. 2022 Mar; 15(3):504-515.
    View in: PubMed
    Score: 0.060
  14. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients. Abdom Radiol (NY). 2016 07; 41(7):1338-48.
    View in: PubMed
    Score: 0.042
  15. Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography. World J Radiol. 2016 Mar 28; 8(3):322-30.
    View in: PubMed
    Score: 0.041
  16. Whole-body FDG PET-MR oncologic imaging: pitfalls in clinical interpretation related to inaccurate MR-based attenuation correction. Abdom Imaging. 2015 Aug; 40(6):1374-86.
    View in: PubMed
    Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.